FDA Approved: DRONABINOL — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for dronabinol filed by Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Chemotherapy-induced Nausea and Vomiting
• HIV Aids-related Weight Loss

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

SUPPL AP for DRONABINOL (DRONABINOL)